I came to the ACS because here, not only am I able to engage in the challenging and rewarding scientific research that I love, I am also able to place a strong emphasis on health equity and mitigating health disparities in my work – both of which I am extremely passionate about, and to which ACS has a genuinely strong commitment.”
Karli Kondo, PhD, MA, is a behavioral scientist and Director of Evidence Synthesis in Early Cancer Detection Science. She leads the Cancer-related Evidence Synthesis Team (CrEST), which conducts the systematic reviews that will support contemporary ACS cancer screening guidelines. Kondo is an internal expert on evidence synthesis methodology.
Dr. Kondo has conducted systematic reviews and evidence maps on a wide range of clinical and health systems topics for the Department of Veterans Affairs, the National Institutes of Health, and the National Academies of Science Engineering and Medicine and is especially interested in factors contributing to health disparities among vulnerable populations and culturally responsive interventions to mitigate them.
Dr. Kondo also has a passion for research ethics and the protection of human subjects. She has served as Vice-Chair of Oregon Health and Science University’s Institutional Review Board since 2016.
For a full list of Dr. Kondo’s publications, visit her Google Scholar page.
I grew up in Hawaii, California, Saudi Arabia, and South Carolina, and now live in Portland, Oregon, with my middle-schooler.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.